IMTXW NASDAQ
immatics biotechnologies GmbH
1W: -92.1%
1M: -96.4%
3M: -98.8%
1Y: -100.0%
3Y: -100.0%
$0.00
Last traded 2025-06-30 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$42M
Revenue
-68.0% YoY
$-207M
Net Income
-179.5% YoY
$-210M
Free Cash Flow
-20.2% YoY
100.0%
Gross Margin
-735.0%
Op. Margin
-683.4%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-47.8%
ROA-39.2%
ROIC-858.3%
Valuation
P/E-0.0
P/B0.0
EV/EBITDA0.0
Leverage
Debt/Equity0.04
Current Ratio7.54
Interest Cov.-237.2x
Quality Scores
Piotroski F2/9
Altman Z—
Beneish M-0.99